Outcome or subgroup title,No. of studies,No. of participants,Statistical method,Effect size,comparison_name,comparison_id,effect_size,lower_ci,upper_ci,outcome_id,subgroup_id,outcome_name,subgroup_name
1 Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration Show forest plot,10,914,"Risk Ratio (M‐H, Fixed, 95% CI)","1.05 [0.68, 1.63]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,1.05,0.68,1.63,1,,Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration,
2 Neurodevelopmental disability Show forest plot,2,208,"Risk Ratio (M‐H, Fixed, 95% CI)","0.82 [0.49, 1.35]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.82,0.49,1.35,2,,Neurodevelopmental disability,
3 IPPV in the delivery room Show forest plot,5,249,"Risk Ratio (M‐H, Fixed, 95% CI)","0.94 [0.83, 1.06]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.94,0.83,1.06,3,,IPPV in the delivery room,
4 Intubation in the delivery room Show forest plot,9,875,"Risk Ratio (M‐H, Fixed, 95% CI)","0.98 [0.82, 1.18]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.98,0.82,1.18,4,,Intubation in the delivery room,
5 Time to reach desired oxygen saturation target Show forest plot,2,102,"Mean Difference (IV, Fixed, 95% CI)","‐0.52 [‐1.83, 0.79]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,-0.52,-1.83,0.79,5,,Time to reach desired oxygen saturation target,
6 Time to reach heart rate > 100 bpm (not prespecified) Show forest plot,1,60,"Mean Difference (IV, Fixed, 95% CI)","0.27 [‐1.21, 1.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.27,-1.21,1.75,6,,Time to reach heart rate > 100 bpm (not prespecified),
7 Retinopathy of prematurity Show forest plot,4,373,"Risk Ratio (M‐H, Fixed, 95% CI)","0.80 [0.43, 1.49]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.8,0.43,1.49,7,,Retinopathy of prematurity,
8 Severe retinopathy of prematurity (≥ stage 3) Show forest plot,4,453,"Risk Ratio (M‐H, Fixed, 95% CI)","0.57 [0.24, 1.36]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.57,0.24,1.36,8,,Severe retinopathy of prematurity (≥ stage 3),
9 Intraventricular haemorrhage Show forest plot,3,271,"Risk Ratio (M‐H, Fixed, 95% CI)","0.81 [0.46, 1.44]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.81,0.46,1.44,9,,Intraventricular haemorrhage,
10 Severe intraventricular haemorrhage (grade 3 or 4) Show forest plot,6,596,"Risk Ratio (M‐H, Fixed, 95% CI)","0.93 [0.51, 1.71]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.93,0.51,1.71,10,,Severe intraventricular haemorrhage (grade 3 or 4),
11 Periventricular leukomalacia Show forest plot,2,130,"Risk Ratio (M‐H, Fixed, 95% CI)","0.66 [0.09, 4.73]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.66,0.09,4.73,11,,Periventricular leukomalacia,
12 Necrotising enterocolitis Show forest plot,8,807,"Risk Ratio (M‐H, Fixed, 95% CI)","0.98 [0.51, 1.87]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.98,0.51,1.87,12,,Necrotising enterocolitis,
13 Chronic lung disease (28 days' age) Show forest plot,2,148,"Risk Ratio (M‐H, Fixed, 95% CI)","0.70 [0.41, 1.21]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.7,0.41,1.21,13,,Chronic lung disease (28 days' age),
14 Chronic lung disease (36 weeks' corrected age) Show forest plot,9,862,"Risk Ratio (M‐H, Fixed, 95% CI)","0.91 [0.72, 1.14]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.91,0.72,1.14,14,,Chronic lung disease (36 weeks' corrected age),
15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) Show forest plot,2,326,"Mean Difference (IV, Fixed, 95% CI)","‐12.39 [‐13.49, ‐11.29]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,-12.39,-13.49,-11.29,15,,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),
16 Duration of respiratory support (mechanical ventilation) (days from birth) Show forest plot,6,510,"Mean Difference (IV, Fixed, 95% CI)","0.61 [‐1.33, 2.54]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.61,-1.33,2.54,16,,Duration of respiratory support (mechanical ventilation) (days from birth),
17 Duration of respiratory support (CPAP) (days from birth) Show forest plot,4,249,"Mean Difference (IV, Fixed, 95% CI)","‐1.60 [‐5.39, 2.19]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,-1.6,-5.39,2.19,17,,Duration of respiratory support (CPAP) (days from birth),
18 Duration of supplemental oxygen administration Show forest plot,5,639,"Mean Difference (IV, Fixed, 95% CI)","9.23 [6.52, 11.95]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,9.23,6.52,11.95,18,,Duration of supplemental oxygen administration,
19 Mortality to follow up (> 18 months) Show forest plot,3,540,"Risk Ratio (M‐H, Fixed, 95% CI)","1.00 [0.59, 1.70]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,1.0,0.59,1.7,19,,Mortality to follow up (> 18 months),
20 Postnatal growth failure (weight < 10th percentile at discharge) Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.86 [0.55, 1.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.86,0.55,1.33,20,,Postnatal growth failure (weight < 10th percentile at discharge),
21 Duration of hospitalisation (days) Show forest plot,3,216,"Mean Difference (IV, Fixed, 95% CI)","‐1.75 [‐12.22, 8.71]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,-1.75,-12.22,8.71,21,,Duration of hospitalisation (days),
22 Patent ductus arteriosus (not prespecified) Show forest plot,7,766,"Risk Ratio (M‐H, Fixed, 95% CI)","0.93 [0.77, 1.14]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration,1,0.93,0.77,1.14,22,,Patent ductus arteriosus (not prespecified),
1 Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration Show forest plot,10,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,1,,Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration,
1.1 FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6,1,13,"Risk Ratio (M‐H, Fixed, 95% CI)","1.17 [0.09, 14.92]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.17,0.09,14.92,1,1,Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration,FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6
1.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,5,495,"Risk Ratio (M‐H, Fixed, 95% CI)","1.70 [0.84, 3.46]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.7,0.84,3.46,1,2,Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration,FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
1.3 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,5,412,"Risk Ratio (M‐H, Fixed, 95% CI)","0.75 [0.42, 1.32]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.75,0.42,1.32,1,3,Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
2 Neurodevelopmental disability Show forest plot,2,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,2,,Neurodevelopmental disability,
2.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,2,208,"Risk Ratio (M‐H, Fixed, 95% CI)","0.82 [0.49, 1.35]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.82,0.49,1.35,2,2,Neurodevelopmental disability,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
3 IPPV in the delivery room Show forest plot,5,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,3,,IPPV in the delivery room,
3.1 FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6,1,13,"Risk Ratio (M‐H, Fixed, 95% CI)","0.7 [0.28, 1.77]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.7,0.28,1.77,3,1,IPPV in the delivery room,FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6
3.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,3,140,"Risk Ratio (M‐H, Fixed, 95% CI)","0.93 [0.77, 1.12]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.93,0.77,1.12,3,2,IPPV in the delivery room,FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
3.3 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,2,102,"Risk Ratio (M‐H, Fixed, 95% CI)","0.96 [0.84, 1.09]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.96,0.84,1.09,3,3,IPPV in the delivery room,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
4 Intubation in the delivery room Show forest plot,9,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,4,,Intubation in the delivery room,
4.1 FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6,1,13,"Risk Ratio (M‐H, Fixed, 95% CI)","0.58 [0.16, 2.14]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.58,0.16,2.14,4,1,Intubation in the delivery room,FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6
4.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,5,495,"Risk Ratio (M‐H, Fixed, 95% CI)","0.93 [0.72, 1.21]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.93,0.72,1.21,4,2,Intubation in the delivery room,FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
4.3 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,4,373,"Risk Ratio (M‐H, Fixed, 95% CI)","1.04 [0.81, 1.34]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.04,0.81,1.34,4,3,Intubation in the delivery room,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
5 Time to reach desired oxygen saturation target Show forest plot,2,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,5,,Time to reach desired oxygen saturation target,
5.1 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,2,102,"Mean Difference (IV, Fixed, 95% CI)","‐0.52 [‐1.83, 0.79]",Lower versus higher oxygen concentration subgrouped by FiO2,2,-0.52,-1.83,0.79,5,1,Time to reach desired oxygen saturation target,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
6 Time to reach heart rate > 100 bpm (not prespecified) Show forest plot,1,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,6,,Time to reach heart rate > 100 bpm (not prespecified),
6.1 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,1,60,"Mean Difference (IV, Fixed, 95% CI)","0.27 [‐1.21, 1.75]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.27,-1.21,1.75,6,1,Time to reach heart rate > 100 bpm (not prespecified),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
7 Retinopathy of prematurity Show forest plot,4,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,7,,Retinopathy of prematurity,
7.1 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,4,373,"Risk Ratio (M‐H, Fixed, 95% CI)","0.80 [0.43, 1.49]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.8,0.43,1.49,7,1,Retinopathy of prematurity,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
8 Severe retinopathy of prematurity (≥ stage 3) Show forest plot,4,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,8,,Severe retinopathy of prematurity (≥ stage 3),
8.1 FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6,1,13,"Risk Ratio (M‐H, Fixed, 95% CI)","0.0 [0.0, 0.0]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.0,0.0,0.0,8,1,Severe retinopathy of prematurity (≥ stage 3),FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6
8.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,3,386,"Risk Ratio (M‐H, Fixed, 95% CI)","0.40 [0.15, 1.05]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.4,0.15,1.05,8,2,Severe retinopathy of prematurity (≥ stage 3),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
8.3 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","3.86 [0.19, 77.05]",Lower versus higher oxygen concentration subgrouped by FiO2,2,3.86,0.19,77.05,8,3,Severe retinopathy of prematurity (≥ stage 3),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
9 Intraventricular haemorrhage Show forest plot,3,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,9,,Intraventricular haemorrhage,
9.1 FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6,1,13,"Risk Ratio (M‐H, Fixed, 95% CI)","0.0 [0.0, 0.0]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.0,0.0,0.0,9,1,Intraventricular haemorrhage,FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6
9.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,1,11,"Risk Ratio (M‐H, Fixed, 95% CI)","0.17 [0.01, 2.92]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.17,0.01,2.92,9,2,Intraventricular haemorrhage,FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
9.3 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","0.85 [0.47, 1.53]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.85,0.47,1.53,9,3,Intraventricular haemorrhage,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
10 Severe intraventricular haemorrhage (grade 3 or 4) Show forest plot,6,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,10,,Severe intraventricular haemorrhage (grade 3 or 4),
10.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,3,416,"Risk Ratio (M‐H, Fixed, 95% CI)","0.78 [0.27, 2.24]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.78,0.27,2.24,10,1,Severe intraventricular haemorrhage (grade 3 or 4),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
10.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,3,180,"Risk Ratio (M‐H, Fixed, 95% CI)","1.03 [0.49, 2.18]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.03,0.49,2.18,10,2,Severe intraventricular haemorrhage (grade 3 or 4),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
11 Periventricular leukomalacia Show forest plot,2,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,11,,Periventricular leukomalacia,
11.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,1,88,"Risk Ratio (M‐H, Fixed, 95% CI)","0.33 [0.01, 7.97]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.33,0.01,7.97,11,1,Periventricular leukomalacia,FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
11.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","1.21 [0.08, 18.09]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.21,0.08,18.09,11,2,Periventricular leukomalacia,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
12 Necrotising enterocolitis Show forest plot,8,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,12,,Necrotising enterocolitis,
12.1 FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6,1,13,"Risk Ratio (M‐H, Fixed, 95% CI)","0.58 [0.07, 4.95]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.58,0.07,4.95,12,1,Necrotising enterocolitis,FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6
12.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,4,434,"Risk Ratio (M‐H, Fixed, 95% CI)","0.74 [0.31, 1.76]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.74,0.31,1.76,12,2,Necrotising enterocolitis,FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
12.3 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,4,373,"Risk Ratio (M‐H, Fixed, 95% CI)","1.40 [0.52, 3.78]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.4,0.52,3.78,12,3,Necrotising enterocolitis,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
13 Chronic lung disease (28 days age) Show forest plot,2,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,13,,Chronic lung disease (28 days age),
13.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,1,88,"Risk Ratio (M‐H, Fixed, 95% CI)","0.47 [0.23, 0.98]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.47,0.23,0.98,13,1,Chronic lung disease (28 days age),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
13.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","1.27 [0.53, 3.05]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.27,0.53,3.05,13,2,Chronic lung disease (28 days age),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
14 Chronic lung disease (36 weeks' corrected age) Show forest plot,9,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,14,,Chronic lung disease (36 weeks' corrected age),
14.1 FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6,1,13,"Risk Ratio (M‐H, Fixed, 95% CI)","0.39 [0.05, 2.83]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.39,0.05,2.83,14,1,Chronic lung disease (36 weeks' corrected age),FiO2 0.21 versus FiO2 ≥ 0.4 to < 0.6
14.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,5,492,"Risk Ratio (M‐H, Fixed, 95% CI)","0.83 [0.63, 1.09]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.83,0.63,1.09,14,2,Chronic lung disease (36 weeks' corrected age),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
14.3 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,4,363,"Risk Ratio (M‐H, Fixed, 95% CI)","1.07 [0.72, 1.60]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.07,0.72,1.6,14,3,Chronic lung disease (36 weeks' corrected age),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) Show forest plot,2,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,15,,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),
15.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,1,266,"Mean Difference (IV, Fixed, 95% CI)","‐13.70 [‐14.85, ‐12.55]",Lower versus higher oxygen concentration subgrouped by FiO2,2,-13.7,-14.85,-12.55,15,1,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
15.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,1,60,"Mean Difference (IV, Fixed, 95% CI)","1.06 [‐2.63, 4.75]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.06,-2.63,4.75,15,2,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
16 Duration of respiratory support (mechanical ventilation) (days from birth) Show forest plot,6,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,16,,Duration of respiratory support (mechanical ventilation) (days from birth),
16.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,3,197,"Mean Difference (IV, Fixed, 95% CI)","‐0.11 [‐4.16, 3.93]",Lower versus higher oxygen concentration subgrouped by FiO2,2,-0.11,-4.16,3.93,16,1,Duration of respiratory support (mechanical ventilation) (days from birth),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
16.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,3,313,"Mean Difference (IV, Fixed, 95% CI)","0.82 [‐1.38, 3.02]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.82,-1.38,3.02,16,2,Duration of respiratory support (mechanical ventilation) (days from birth),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
17 Duration of respiratory support (CPAP) (days from birth) Show forest plot,4,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,17,,Duration of respiratory support (CPAP) (days from birth),
17.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,2,129,"Mean Difference (IV, Fixed, 95% CI)","‐1.79 [‐5.84, 2.25]",Lower versus higher oxygen concentration subgrouped by FiO2,2,-1.79,-5.84,2.25,17,1,Duration of respiratory support (CPAP) (days from birth),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
17.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,2,120,"Mean Difference (IV, Fixed, 95% CI)","‐0.24 [‐11.00, 10.53]",Lower versus higher oxygen concentration subgrouped by FiO2,2,-0.24,-11.0,10.53,17,2,Duration of respiratory support (CPAP) (days from birth),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
18 Duration of supplemental oxygen administration Show forest plot,5,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,18,,Duration of supplemental oxygen administration,
18.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,1,266,"Mean Difference (IV, Fixed, 95% CI)","12.4 [9.25, 15.55]",Lower versus higher oxygen concentration subgrouped by FiO2,2,12.4,9.25,15.55,18,1,Duration of supplemental oxygen administration,FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
18.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,4,373,"Mean Difference (IV, Fixed, 95% CI)","0.01 [‐5.37, 5.38]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.01,-5.37,5.38,18,2,Duration of supplemental oxygen administration,FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
19 Mortality to follow up (> 18 months) Show forest plot,3,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,19,,Mortality to follow up (> 18 months),
19.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,1,287,"Risk Ratio (M‐H, Fixed, 95% CI)","2.32 [0.92, 5.86]",Lower versus higher oxygen concentration subgrouped by FiO2,2,2.32,0.92,5.86,19,1,Mortality to follow up (> 18 months),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
19.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","0.56 [0.28, 1.14]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.56,0.28,1.14,19,2,Mortality to follow up (> 18 months),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
20 Postnatal growth failure (weight < 10th percentile at discharge) Show forest plot,1,,"Risk Ratio (M‐H, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,20,,Postnatal growth failure (weight < 10th percentile at discharge),
20.1 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.86 [0.55, 1.33]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.86,0.55,1.33,20,1,Postnatal growth failure (weight < 10th percentile at discharge),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
21 Duration of hospitalisation (days) Show forest plot,3,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Lower versus higher oxygen concentration subgrouped by FiO2,2,,,,21,,Duration of hospitalisation (days),
21.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,2,156,"Mean Difference (IV, Fixed, 95% CI)","‐4.35 [‐15.26, 6.57]",Lower versus higher oxygen concentration subgrouped by FiO2,2,-4.35,-15.26,6.57,21,1,Duration of hospitalisation (days),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
21.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,1,60,"Mean Difference (IV, Fixed, 95% CI)","28.0 [‐8.96, 64.96]",Lower versus higher oxygen concentration subgrouped by FiO2,2,28.0,-8.96,64.96,21,2,Duration of hospitalisation (days),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
22 Patent ductus arteriosus (not prespecified) Show forest plot,7,766,"Risk Ratio (M‐H, Fixed, 95% CI)","0.93 [0.77, 1.14]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.93,0.77,1.14,22,,Patent ductus arteriosus (not prespecified),
22.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0,3,393,"Risk Ratio (M‐H, Fixed, 95% CI)","0.80 [0.57, 1.14]",Lower versus higher oxygen concentration subgrouped by FiO2,2,0.8,0.57,1.14,22,1,Patent ductus arteriosus (not prespecified),FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0
22.2 FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0,4,373,"Risk Ratio (M‐H, Fixed, 95% CI)","1.03 [0.82, 1.29]",Lower versus higher oxygen concentration subgrouped by FiO2,2,1.03,0.82,1.29,22,2,Patent ductus arteriosus (not prespecified),FiO2 ≥ 0.3 to < 0.4 versus FiO2 ≥ 0.6 to 1.0
1 Mortality near term corrected age or discharge (latest reported) Show forest plot,10,914,"Risk Ratio (M‐H, Fixed, 95% CI)","1.05 [0.68, 1.63]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,1.05,0.68,1.63,1,,Mortality near term corrected age or discharge (latest reported),
1.1 SpO2 target < 85%,1,287,"Risk Ratio (M‐H, Fixed, 95% CI)","2.78 [1.03, 7.52]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,2.78,1.03,7.52,1,1,Mortality near term corrected age or discharge (latest reported),SpO2 target < 85%
1.2 SpO2 target 85 to 90%,9,627,"Risk Ratio (M‐H, Fixed, 95% CI)","0.77 [0.46, 1.27]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.77,0.46,1.27,1,2,Mortality near term corrected age or discharge (latest reported),SpO2 target 85 to 90%
2 Neurodevelopmental disability Show forest plot,2,208,"Risk Ratio (M‐H, Fixed, 95% CI)","0.82 [0.49, 1.35]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.82,0.49,1.35,2,,Neurodevelopmental disability,
2.1 SpO2 target 85 to 90%,2,208,"Risk Ratio (M‐H, Fixed, 95% CI)","0.82 [0.49, 1.35]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.82,0.49,1.35,2,1,Neurodevelopmental disability,SpO2 target 85 to 90%
3 IPPV in the delivery room Show forest plot,5,249,"Risk Ratio (M‐H, Fixed, 95% CI)","0.94 [0.83, 1.06]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.94,0.83,1.06,3,,IPPV in the delivery room,
3.1 SpO2 target 85 to 90%,5,249,"Risk Ratio (M‐H, Fixed, 95% CI)","0.94 [0.83, 1.06]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.94,0.83,1.06,3,1,IPPV in the delivery room,SpO2 target 85 to 90%
4 Intubation in the delivery room Show forest plot,9,875,"Risk Ratio (M‐H, Fixed, 95% CI)","0.98 [0.82, 1.18]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.98,0.82,1.18,4,,Intubation in the delivery room,
4.1 SpO2 target < 85%,1,287,"Risk Ratio (M‐H, Fixed, 95% CI)","1.04 [0.73, 1.49]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,1.04,0.73,1.49,4,1,Intubation in the delivery room,SpO2 target < 85%
4.2 SpO2 target 85 to 90%,8,588,"Risk Ratio (M‐H, Fixed, 95% CI)","0.96 [0.78, 1.18]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.96,0.78,1.18,4,2,Intubation in the delivery room,SpO2 target 85 to 90%
5 Time to reach desired oxygen saturation target Show forest plot,2,102,"Mean Difference (IV, Fixed, 95% CI)","‐0.52 [‐1.83, 0.79]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,-0.52,-1.83,0.79,5,,Time to reach desired oxygen saturation target,
5.1 SpO2 target 85 to 90%,2,102,"Mean Difference (IV, Fixed, 95% CI)","‐0.52 [‐1.83, 0.79]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,-0.52,-1.83,0.79,5,1,Time to reach desired oxygen saturation target,SpO2 target 85 to 90%
6 Time to reach heart rate > 100 bpm (not prespecified) Show forest plot,1,60,"Mean Difference (IV, Fixed, 95% CI)","0.27 [‐1.21, 1.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.27,-1.21,1.75,6,,Time to reach heart rate > 100 bpm (not prespecified),
6.1 SpO2 target 85 to 90%,1,60,"Mean Difference (IV, Fixed, 95% CI)","0.27 [‐1.21, 1.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.27,-1.21,1.75,6,1,Time to reach heart rate > 100 bpm (not prespecified),SpO2 target 85 to 90%
7 Retinopathy of prematurity Show forest plot,4,373,"Risk Ratio (M‐H, Fixed, 95% CI)","0.80 [0.43, 1.49]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.8,0.43,1.49,7,,Retinopathy of prematurity,
7.1 SpO2 target 85 to 90%,4,373,"Risk Ratio (M‐H, Fixed, 95% CI)","0.80 [0.43, 1.49]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.8,0.43,1.49,7,1,Retinopathy of prematurity,SpO2 target 85 to 90%
8 Severe retinopathy of prematurity (≥ stage 3) Show forest plot,4,453,"Risk Ratio (M‐H, Fixed, 95% CI)","0.57 [0.24, 1.36]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.57,0.24,1.36,8,,Severe retinopathy of prematurity (≥ stage 3),
8.1 SpO2 target < 85%,1,287,"Risk Ratio (M‐H, Fixed, 95% CI)","0.50 [0.15, 1.61]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.5,0.15,1.61,8,1,Severe retinopathy of prematurity (≥ stage 3),SpO2 target < 85%
8.2 SpO2 target 85 to 90%,3,166,"Risk Ratio (M‐H, Fixed, 95% CI)","0.68 [0.19, 2.48]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.68,0.19,2.48,8,2,Severe retinopathy of prematurity (≥ stage 3),SpO2 target 85 to 90%
9 Intraventricular haemorrhage Show forest plot,3,271,"Risk Ratio (M‐H, Fixed, 95% CI)","0.81 [0.46, 1.44]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.81,0.46,1.44,9,,Intraventricular haemorrhage,
9.1 SpO2 target 85 to 90%,3,271,"Risk Ratio (M‐H, Fixed, 95% CI)","0.81 [0.46, 1.44]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.81,0.46,1.44,9,1,Intraventricular haemorrhage,SpO2 target 85 to 90%
10 Severe intraventricular haemorrhage (grade 3 or 4) Show forest plot,6,596,"Risk Ratio (M‐H, Fixed, 95% CI)","0.93 [0.51, 1.71]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.93,0.51,1.71,10,,Severe intraventricular haemorrhage (grade 3 or 4),
10.1 SpO2 target < 85%,1,287,"Risk Ratio (M‐H, Fixed, 95% CI)","0.33 [0.07, 1.61]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.33,0.07,1.61,10,1,Severe intraventricular haemorrhage (grade 3 or 4),SpO2 target < 85%
10.2 SpO2 target 85 to 90%,5,309,"Risk Ratio (M‐H, Fixed, 95% CI)","1.21 [0.61, 2.39]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,1.21,0.61,2.39,10,2,Severe intraventricular haemorrhage (grade 3 or 4),SpO2 target 85 to 90%
11 Periventricular leukomalacia Show forest plot,2,130,"Risk Ratio (M‐H, Fixed, 95% CI)","0.66 [0.09, 4.73]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.66,0.09,4.73,11,,Periventricular leukomalacia,
11.1 SpO2 target 85 to 90%,2,130,"Risk Ratio (M‐H, Fixed, 95% CI)","0.66 [0.09, 4.73]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.66,0.09,4.73,11,1,Periventricular leukomalacia,SpO2 target 85 to 90%
12 Necrotising enterocolitis Show forest plot,8,807,"Risk Ratio (M‐H, Fixed, 95% CI)","0.98 [0.51, 1.87]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.98,0.51,1.87,12,,Necrotising enterocolitis,
12.1 SpO2 target < 85%,1,287,"Risk Ratio (M‐H, Fixed, 95% CI)","4.97 [0.59, 41.97]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,4.97,0.59,41.97,12,1,Necrotising enterocolitis,SpO2 target < 85%
12.2 SpO2 target 85 to 90%,7,520,"Risk Ratio (M‐H, Fixed, 95% CI)","0.74 [0.36, 1.52]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.74,0.36,1.52,12,2,Necrotising enterocolitis,SpO2 target 85 to 90%
13 Chronic lung disease (28 days' age) Show forest plot,2,148,"Risk Ratio (M‐H, Fixed, 95% CI)","0.70 [0.41, 1.21]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.7,0.41,1.21,13,,Chronic lung disease (28 days' age),
13.1 SpO2 target 85 to 90%,2,148,"Risk Ratio (M‐H, Fixed, 95% CI)","0.70 [0.41, 1.21]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.7,0.41,1.21,13,1,Chronic lung disease (28 days' age),SpO2 target 85 to 90%
14 Chronic lung disease (36 weeks' corrected age) Show forest plot,9,862,"Risk Ratio (M‐H, Random, 95% CI)","0.91 [0.64, 1.29]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.91,0.64,1.29,14,,Chronic lung disease (36 weeks' corrected age),
14.1 SpO2 target < 85%,1,287,"Risk Ratio (M‐H, Random, 95% CI)","0.84 [0.57, 1.25]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.84,0.57,1.25,14,1,Chronic lung disease (36 weeks' corrected age),SpO2 target < 85%
14.2 SpO2 target 85 to 90%,8,575,"Risk Ratio (M‐H, Random, 95% CI)","0.91 [0.58, 1.43]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.91,0.58,1.43,14,2,Chronic lung disease (36 weeks' corrected age),SpO2 target 85 to 90%
15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) Show forest plot,2,326,"Mean Difference (IV, Fixed, 95% CI)","‐12.39 [‐13.49, ‐11.29]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,-12.39,-13.49,-11.29,15,,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),
15.1 SpO2 target < 85%,1,266,"Mean Difference (IV, Fixed, 95% CI)","‐13.70 [‐14.85, ‐12.55]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,-13.7,-14.85,-12.55,15,1,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),SpO2 target < 85%
15.2 SpO2 target 85 to 90%,1,60,"Mean Difference (IV, Fixed, 95% CI)","1.06 [‐2.63, 4.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,1.06,-2.63,4.75,15,2,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),SpO2 target 85 to 90%
16 Duration of respiratory support (mechanical ventilation) (days from birth) Show forest plot,6,510,"Mean Difference (IV, Fixed, 95% CI)","0.78 [‐1.15, 2.72]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.78,-1.15,2.72,16,,Duration of respiratory support (mechanical ventilation) (days from birth),
16.1 SpO2 target 85 to 90%,6,510,"Mean Difference (IV, Fixed, 95% CI)","0.78 [‐1.15, 2.72]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.78,-1.15,2.72,16,1,Duration of respiratory support (mechanical ventilation) (days from birth),SpO2 target 85 to 90%
17 Duration of respiratory support (CPAP) (days from birth) Show forest plot,4,249,"Mean Difference (IV, Fixed, 95% CI)","‐1.83 [‐5.62, 1.96]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,-1.83,-5.62,1.96,17,,Duration of respiratory support (CPAP) (days from birth),
17.1 SpO2 target 85 to 90%,4,249,"Mean Difference (IV, Fixed, 95% CI)","‐1.83 [‐5.62, 1.96]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,-1.83,-5.62,1.96,17,1,Duration of respiratory support (CPAP) (days from birth),SpO2 target 85 to 90%
18 Duration of supplemental oxygen administration Show forest plot,5,639,"Mean Difference (IV, Fixed, 95% CI)","9.67 [6.96, 12.39]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,9.67,6.96,12.39,18,,Duration of supplemental oxygen administration,
18.1 SpO2 target < 85%,1,266,"Mean Difference (IV, Fixed, 95% CI)","12.4 [9.25, 15.55]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,12.4,9.25,15.55,18,1,Duration of supplemental oxygen administration,SpO2 target < 85%
18.2 SpO2 target 85 to 90%,4,373,"Mean Difference (IV, Fixed, 95% CI)","1.73 [‐3.64, 7.11]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,1.73,-3.64,7.11,18,2,Duration of supplemental oxygen administration,SpO2 target 85 to 90%
19 Mortality to follow up (> 18 months) Show forest plot,3,540,"Risk Ratio (M‐H, Fixed, 95% CI)","1.00 [0.59, 1.70]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,1.0,0.59,1.7,19,,Mortality to follow up (> 18 months),
19.1 SpO2 target < 85%,1,287,"Risk Ratio (M‐H, Fixed, 95% CI)","2.32 [0.92, 5.86]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,2.32,0.92,5.86,19,1,Mortality to follow up (> 18 months),SpO2 target < 85%
19.2 SpO2 target 85 to 90%,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","0.56 [0.28, 1.14]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.56,0.28,1.14,19,2,Mortality to follow up (> 18 months),SpO2 target 85 to 90%
20 Postnatal growth failure (weight < 10th percentile at discharge) Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.86 [0.55, 1.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.86,0.55,1.33,20,,Postnatal growth failure (weight < 10th percentile at discharge),
20.1 SpO2 target 85 to 90%,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.86 [0.55, 1.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.86,0.55,1.33,20,1,Postnatal growth failure (weight < 10th percentile at discharge),SpO2 target 85 to 90%
21 Duration of hospitalisation (days) Show forest plot,3,216,"Mean Difference (IV, Fixed, 95% CI)","‐1.75 [‐12.22, 8.71]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,-1.75,-12.22,8.71,21,,Duration of hospitalisation (days),
21.1 SpO2 target 85 to 90%,3,216,"Mean Difference (IV, Fixed, 95% CI)","‐1.75 [‐12.22, 8.71]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,-1.75,-12.22,8.71,21,1,Duration of hospitalisation (days),SpO2 target 85 to 90%
22 Patent ductus arteriosus (not prespecified) Show forest plot,7,766,"Risk Ratio (M‐H, Fixed, 95% CI)","0.95 [0.79, 1.15]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.95,0.79,1.15,22,,Patent ductus arteriosus (not prespecified),
22.1 SpO2 target < 85%,1,287,"Risk Ratio (M‐H, Fixed, 95% CI)","0.87 [0.59, 1.28]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.87,0.59,1.28,22,1,Patent ductus arteriosus (not prespecified),SpO2 target < 85%
22.2 SpO2 target 85 to 90%,6,479,"Risk Ratio (M‐H, Fixed, 95% CI)","0.98 [0.79, 1.22]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues,3,0.98,0.79,1.22,22,2,Patent ductus arteriosus (not prespecified),SpO2 target 85 to 90%
1 Mortality near term corrected age or discharge (latest reported) Show forest plot,7,737,"Risk Ratio (M‐H, Fixed, 95% CI)","1.21 [0.72, 2.02]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,1.21,0.72,2.02,1,,Mortality near term corrected age or discharge (latest reported),
1.1 SpO2 target 85 to 90%,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","1.61 [0.41, 6.34]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,1.61,0.41,6.34,1,1,Mortality near term corrected age or discharge (latest reported),SpO2 target 85 to 90%
1.2 SpO2 target 91 to 95%,6,695,"Risk Ratio (M‐H, Fixed, 95% CI)","1.16 [0.67, 2.01]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,1.16,0.67,2.01,1,2,Mortality near term corrected age or discharge (latest reported),SpO2 target 91 to 95%
2 Neurodevelopmental disability Show forest plot,1,177,"Risk Ratio (M‐H, Fixed, 95% CI)","0.71 [0.42, 1.21]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.71,0.42,1.21,2,,Neurodevelopmental disability,
2.1 SpO2 target 91 to 95%,1,177,"Risk Ratio (M‐H, Fixed, 95% CI)","0.71 [0.42, 1.21]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.71,0.42,1.21,2,1,Neurodevelopmental disability,SpO2 target 91 to 95%
3 IPPV in the delivery room Show forest plot,4,189,"Risk Ratio (M‐H, Fixed, 95% CI)","0.91 [0.77, 1.08]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.91,0.77,1.08,3,,IPPV in the delivery room,
3.1 SpO2 target 85 to 90%,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","0.87 [0.60, 1.27]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.87,0.6,1.27,3,1,IPPV in the delivery room,SpO2 target 85 to 90%
3.2 SpO2 target 91 to 95%,3,147,"Risk Ratio (M‐H, Fixed, 95% CI)","0.92 [0.76, 1.12]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.92,0.76,1.12,3,2,IPPV in the delivery room,SpO2 target 91 to 95%
4 Intubation in the delivery room Show forest plot,7,737,"Risk Ratio (M‐H, Fixed, 95% CI)","0.96 [0.78, 1.18]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.96,0.78,1.18,4,,Intubation in the delivery room,
4.1 SpO2 target 85 to 90%,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","0.91 [0.49, 1.68]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.91,0.49,1.68,4,1,Intubation in the delivery room,SpO2 target 85 to 90%
4.2 SpO2 target 91 to 95%,6,695,"Risk Ratio (M‐H, Fixed, 95% CI)","0.96 [0.77, 1.20]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.96,0.77,1.2,4,2,Intubation in the delivery room,SpO2 target 91 to 95%
5 Time to reach desired oxygen saturation target Show forest plot,1,42,"Mean Difference (IV, Fixed, 95% CI)","‐1.70 [‐3.28, ‐0.12]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-1.7,-3.28,-0.12,5,,Time to reach desired oxygen saturation target,
5.1 SpO2 target 85 to 90%,1,42,"Mean Difference (IV, Fixed, 95% CI)","‐1.70 [‐3.28, ‐0.12]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-1.7,-3.28,-0.12,5,1,Time to reach desired oxygen saturation target,SpO2 target 85 to 90%
6 Retinopathy of prematurity Show forest plot,2,235,"Risk Ratio (M‐H, Fixed, 95% CI)","1.00 [0.36, 2.79]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,1.0,0.36,2.79,6,,Retinopathy of prematurity,
6.1 SpO2 target 85 to 90%,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","0.61 [0.06, 6.17]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.61,0.06,6.17,6,1,Retinopathy of prematurity,SpO2 target 85 to 90%
6.2 SpO2 target 91 to 95%,1,193,"Risk Ratio (M‐H, Fixed, 95% CI)","1.14 [0.36, 3.61]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,1.14,0.36,3.61,6,2,Retinopathy of prematurity,SpO2 target 91 to 95%
7 Severe retinopathy of prematurity (≥ stage 3) Show forest plot,3,393,"Risk Ratio (M‐H, Fixed, 95% CI)","0.43 [0.16, 1.14]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.43,0.16,1.14,7,,Severe retinopathy of prematurity (≥ stage 3),
7.1 SpO2 target 91 to 95%,3,393,"Risk Ratio (M‐H, Fixed, 95% CI)","0.43 [0.16, 1.14]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.43,0.16,1.14,7,1,Severe retinopathy of prematurity (≥ stage 3),SpO2 target 91 to 95%
8 Intraventricular haemorrhage Show forest plot,2,211,"Risk Ratio (M‐H, Fixed, 95% CI)","0.70 [0.30, 1.64]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.7,0.3,1.64,8,,Intraventricular haemorrhage,
8.1 SpO2 target 91 to 95%,2,211,"Risk Ratio (M‐H, Fixed, 95% CI)","0.70 [0.30, 1.64]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.7,0.3,1.64,8,1,Intraventricular haemorrhage,SpO2 target 91 to 95%
9 Severe intraventricular haemorrhage (grade 3 or 4) Show forest plot,4,458,"Risk Ratio (M‐H, Fixed, 95% CI)","0.72 [0.30, 1.73]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.72,0.3,1.73,9,,Severe intraventricular haemorrhage (grade 3 or 4),
9.1 SpO2 target 85 to 90%,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","0.61 [0.12, 2.95]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.61,0.12,2.95,9,1,Severe intraventricular haemorrhage (grade 3 or 4),SpO2 target 85 to 90%
9.2 SpO2 target 91 to 95%,3,416,"Risk Ratio (M‐H, Fixed, 95% CI)","0.78 [0.27, 2.24]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.78,0.27,2.24,9,2,Severe intraventricular haemorrhage (grade 3 or 4),SpO2 target 91 to 95%
10 Periventricular leukomalacia Show forest plot,2,130,"Risk Ratio (M‐H, Fixed, 95% CI)","0.66 [0.09, 4.73]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.66,0.09,4.73,10,,Periventricular leukomalacia,
10.1 SpO2 target 85 to 90%,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","1.21 [0.08, 18.09]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,1.21,0.08,18.09,10,1,Periventricular leukomalacia,SpO2 target 85 to 90%
10.2 SpO2 target 91 to 95%,1,88,"Risk Ratio (M‐H, Fixed, 95% CI)","0.33 [0.01, 7.97]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.33,0.01,7.97,10,2,Periventricular leukomalacia,SpO2 target 91 to 95%
11 Necrotising enterocolitis Show forest plot,6,669,"Risk Ratio (M‐H, Fixed, 95% CI)","0.81 [0.39, 1.67]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.81,0.39,1.67,11,,Necrotising enterocolitis,
11.1 SpO2 target 85 to 90%,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","0.4 [0.02, 9.29]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.4,0.02,9.29,11,1,Necrotising enterocolitis,SpO2 target 85 to 90%
11.2 SpO2 target 91 to 95%,5,627,"Risk Ratio (M‐H, Fixed, 95% CI)","0.85 [0.40, 1.79]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.85,0.4,1.79,11,2,Necrotising enterocolitis,SpO2 target 91 to 95%
12 Chronic lung disease (28 days age) Show forest plot,1,88,"Risk Ratio (M‐H, Fixed, 95% CI)","0.47 [0.23, 0.98]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.47,0.23,0.98,12,,Chronic lung disease (28 days age),
12.1 SpO2 target 91 to 95%,1,88,"Risk Ratio (M‐H, Fixed, 95% CI)","0.47 [0.23, 0.98]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.47,0.23,0.98,12,1,Chronic lung disease (28 days age),SpO2 target 91 to 95%
13 Chronic lung disease (36 weeks' corrected age) Show forest plot,7,734,"Risk Ratio (M‐H, Fixed, 95% CI)","0.93 [0.73, 1.19]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.93,0.73,1.19,13,,Chronic lung disease (36 weeks' corrected age),
13.1 SpO2 target 85 to 90%,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","0.73 [0.20, 2.65]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.73,0.2,2.65,13,1,Chronic lung disease (36 weeks' corrected age),SpO2 target 85 to 90%
13.2 SpO2 target 91 to 95%,6,692,"Risk Ratio (M‐H, Fixed, 95% CI)","0.94 [0.74, 1.21]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.94,0.74,1.21,13,2,Chronic lung disease (36 weeks' corrected age),SpO2 target 91 to 95%
14 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) Show forest plot,1,266,"Mean Difference (IV, Fixed, 95% CI)","‐13.70 [‐14.85, ‐12.55]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-13.7,-14.85,-12.55,14,,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),
14.1 SpO2 target 91 to 95%,1,266,"Mean Difference (IV, Fixed, 95% CI)","‐13.70 [‐14.85, ‐12.55]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-13.7,-14.85,-12.55,14,1,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),SpO2 target 91 to 95%
15 Duration of respiratory support (mechanical ventilation) (days from birth) Show forest plot,5,432,"Mean Difference (IV, Fixed, 95% CI)","0.91 [‐1.02, 2.85]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.91,-1.02,2.85,15,,Duration of respiratory support (mechanical ventilation) (days from birth),
15.1 SpO2 target 85 to 90%,1,42,"Mean Difference (IV, Fixed, 95% CI)","‐4.75 [‐37.24, 27.74]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-4.75,-37.24,27.74,15,1,Duration of respiratory support (mechanical ventilation) (days from birth),SpO2 target 85 to 90%
15.2 SpO2 target 91 to 95%,4,390,"Mean Difference (IV, Fixed, 95% CI)","0.94 [‐1.01, 2.88]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.94,-1.01,2.88,15,2,Duration of respiratory support (mechanical ventilation) (days from birth),SpO2 target 91 to 95%
16 Duration of respiratory support (CPAP) (days from birth) Show forest plot,3,171,"Mean Difference (IV, Fixed, 95% CI)","‐3.11 [‐7.08, 0.86]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-3.11,-7.08,0.86,16,,Duration of respiratory support (CPAP) (days from birth),
16.1 SpO2 target 85 to 90%,1,42,"Mean Difference (IV, Fixed, 95% CI)","12.0 [‐9.18, 33.18]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,12.0,-9.18,33.18,16,1,Duration of respiratory support (CPAP) (days from birth),SpO2 target 85 to 90%
16.2 Higher SpO2 target 91 to 95%,2,129,"Mean Difference (IV, Fixed, 95% CI)","‐3.66 [‐7.71, 0.38]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-3.66,-7.71,0.38,16,2,Duration of respiratory support (CPAP) (days from birth),Higher SpO2 target 91 to 95%
17 Duration of supplemental oxygen administration Show forest plot,3,501,"Mean Difference (IV, Fixed, 95% CI)","9.87 [7.12, 12.62]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,9.87,7.12,12.62,17,,Duration of supplemental oxygen administration,
17.1 SpO2 target 85 to 90%,1,42,"Mean Difference (IV, Fixed, 95% CI)","‐10.25 [‐50.97, 30.47]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-10.25,-50.97,30.47,17,1,Duration of supplemental oxygen administration,SpO2 target 85 to 90%
17.2 SpO2 target 91 to 95%,2,459,"Mean Difference (IV, Fixed, 95% CI)","9.96 [7.21, 12.71]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,9.96,7.21,12.71,17,2,Duration of supplemental oxygen administration,SpO2 target 91 to 95%
18 Mortality to follow up (> 18 months) Show forest plot,2,480,"Risk Ratio (M‐H, Fixed, 95% CI)","1.22 [0.65, 2.29]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,1.22,0.65,2.29,18,,Mortality to follow up (> 18 months),
18.1 SpO2 target 91 to 95%,2,480,"Risk Ratio (M‐H, Fixed, 95% CI)","1.22 [0.65, 2.29]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,1.22,0.65,2.29,18,1,Mortality to follow up (> 18 months),SpO2 target 91 to 95%
19 Duration of hospitalisation (days) Show forest plot,2,156,"Mean Difference (IV, Fixed, 95% CI)","‐4.35 [‐15.26, 6.57]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-4.35,-15.26,6.57,19,,Duration of hospitalisation (days),
19.1 SpO2 target 91 to 95%,2,156,"Mean Difference (IV, Fixed, 95% CI)","‐4.35 [‐15.26, 6.57]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,-4.35,-15.26,6.57,19,1,Duration of hospitalisation (days),SpO2 target 91 to 95%
20 Patent ductus arteriosus (not prespecified) Show forest plot,5,628,"Risk Ratio (M‐H, Fixed, 95% CI)","0.96 [0.75, 1.22]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.96,0.75,1.22,20,,Patent ductus arteriosus (not prespecified),
20.1 SpO2 target 85 to 90%,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","1.10 [0.60, 2.01]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,1.1,0.6,2.01,20,1,Patent ductus arteriosus (not prespecified),SpO2 target 85 to 90%
20.2 SpO2 target 91 to 95%,4,586,"Risk Ratio (M‐H, Fixed, 95% CI)","0.94 [0.72, 1.22]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes,4,0.94,0.72,1.22,20,2,Patent ductus arteriosus (not prespecified),SpO2 target 91 to 95%
1 Mortality near term corrected age or discharge (latest reported) Show forest plot,8,832,"Risk Ratio (M‐H, Fixed, 95% CI)","1.01 [0.66, 1.55]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.01,0.66,1.55,1,,Mortality near term corrected age or discharge (latest reported),
1.1 Gestation ≤ 28 weeks,8,516,"Risk Ratio (M‐H, Fixed, 95% CI)","1.04 [0.68, 1.61]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.04,0.68,1.61,1,1,Mortality near term corrected age or discharge (latest reported),Gestation ≤ 28 weeks
1.2 Gestation > 28 to 32 weeks,4,316,"Risk Ratio (M‐H, Fixed, 95% CI)","0.5 [0.05, 5.26]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.5,0.05,5.26,1,2,Mortality near term corrected age or discharge (latest reported),Gestation > 28 to 32 weeks
2 Neurodevelopmental disability Show forest plot,1,31,"Risk Ratio (M‐H, Fixed, 95% CI)","3.64 [0.42, 31.27]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,3.64,0.42,31.27,2,,Neurodevelopmental disability,
2.1 Gestation ≤ 28 weeks,1,31,"Risk Ratio (M‐H, Fixed, 95% CI)","3.64 [0.42, 31.27]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,3.64,0.42,31.27,2,1,Neurodevelopmental disability,Gestation ≤ 28 weeks
3 IPPV in the delivery room Show forest plot,2,102,"Risk Ratio (M‐H, Fixed, 95% CI)","0.96 [0.84, 1.09]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.96,0.84,1.09,3,,IPPV in the delivery room,
3.1 Gestation ≤ 28 weeks,2,102,"Risk Ratio (M‐H, Fixed, 95% CI)","0.96 [0.84, 1.09]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.96,0.84,1.09,3,1,IPPV in the delivery room,Gestation ≤ 28 weeks
4 Intubation in the delivery room Show forest plot,4,467,"Risk Ratio (M‐H, Fixed, 95% CI)","1.08 [0.85, 1.35]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.08,0.85,1.35,4,,Intubation in the delivery room,
4.1 Gestation ≤ 28 weeks,4,338,"Risk Ratio (M‐H, Fixed, 95% CI)","1.06 [0.84, 1.34]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.06,0.84,1.34,4,1,Intubation in the delivery room,Gestation ≤ 28 weeks
4.2 Gestation > 28 to 32 weeks,1,129,"Risk Ratio (M‐H, Fixed, 95% CI)","1.20 [0.49, 2.97]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.2,0.49,2.97,4,2,Intubation in the delivery room,Gestation > 28 to 32 weeks
5 Time to reach desired oxygen saturation target Show forest plot,2,102,"Mean Difference (IV, Fixed, 95% CI)","‐0.52 [‐1.83, 0.79]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,-0.52,-1.83,0.79,5,,Time to reach desired oxygen saturation target,
5.1 Gestation ≤ 28 weeks,2,102,"Mean Difference (IV, Fixed, 95% CI)","‐0.52 [‐1.83, 0.79]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,-0.52,-1.83,0.79,5,1,Time to reach desired oxygen saturation target,Gestation ≤ 28 weeks
6 Time to reach heart rate > 100 bpm Show forest plot,1,60,"Mean Difference (IV, Fixed, 95% CI)","0.27 [‐1.21, 1.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.27,-1.21,1.75,6,,Time to reach heart rate > 100 bpm,
6.1 Gestation ≤ 28 weeks,1,60,"Mean Difference (IV, Fixed, 95% CI)","0.27 [‐1.21, 1.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.27,-1.21,1.75,6,1,Time to reach heart rate > 100 bpm,Gestation ≤ 28 weeks
7 Retinopathy of prematurity Show forest plot,4,259,"Risk Ratio (M‐H, Fixed, 95% CI)","0.72 [0.38, 1.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.72,0.38,1.33,7,,Retinopathy of prematurity,
7.1 Gestation ≤ 28 weeks,4,259,"Risk Ratio (M‐H, Fixed, 95% CI)","0.72 [0.38, 1.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.72,0.38,1.33,7,1,Retinopathy of prematurity,Gestation ≤ 28 weeks
8 Severe retinopathy of prematurity (≥ stage 3) Show forest plot,5,464,"Risk Ratio (M‐H, Fixed, 95% CI)","0.93 [0.46, 1.89]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.93,0.46,1.89,8,,Severe retinopathy of prematurity (≥ stage 3),
8.1 Gestation ≤ 28 weeks,5,317,"Risk Ratio (M‐H, Fixed, 95% CI)","0.88 [0.43, 1.82]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.88,0.43,1.82,8,1,Severe retinopathy of prematurity (≥ stage 3),Gestation ≤ 28 weeks
8.2 Gestation > 28 to 32 weeks,1,147,"Risk Ratio (M‐H, Fixed, 95% CI)","2.26 [0.09, 54.54]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,2.26,0.09,54.54,8,2,Severe retinopathy of prematurity (≥ stage 3),Gestation > 28 to 32 weeks
9 Intraventricular haemorrhage Show forest plot,2,217,"Risk Ratio (M‐H, Fixed, 95% CI)","0.87 [0.52, 1.48]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.87,0.52,1.48,9,,Intraventricular haemorrhage,
9.1 Gestation ≤ 28 weeks,2,217,"Risk Ratio (M‐H, Fixed, 95% CI)","0.87 [0.52, 1.48]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.87,0.52,1.48,9,1,Intraventricular haemorrhage,Gestation ≤ 28 weeks
10 Severe intraventricular haemorrhage (grade 3 or 4) Show forest plot,6,537,"Risk Ratio (M‐H, Fixed, 95% CI)","1.02 [0.55, 1.87]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.02,0.55,1.87,10,,Severe intraventricular haemorrhage (grade 3 or 4),
10.1 Gestation ≤ 28 weeks,6,388,"Risk Ratio (M‐H, Fixed, 95% CI)","0.95 [0.51, 1.79]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.95,0.51,1.79,10,1,Severe intraventricular haemorrhage (grade 3 or 4),Gestation ≤ 28 weeks
10.2 Gestation > 28 to 32 weeks,2,149,"Risk Ratio (M‐H, Fixed, 95% CI)","3.27 [0.15, 72.23]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,3.27,0.15,72.23,10,2,Severe intraventricular haemorrhage (grade 3 or 4),Gestation > 28 to 32 weeks
11 Periventricular leukomalacia Show forest plot,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","1.21 [0.08, 18.09]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.21,0.08,18.09,11,,Periventricular leukomalacia,
11.1 Gestation ≤ 28 weeks,1,42,"Risk Ratio (M‐H, Fixed, 95% CI)","1.21 [0.08, 18.09]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.21,0.08,18.09,11,1,Periventricular leukomalacia,Gestation ≤ 28 weeks
12 Necrotising enterocolitis Show forest plot,7,731,"Risk Ratio (M‐H, Fixed, 95% CI)","1.57 [0.78, 3.17]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.57,0.78,3.17,12,,Necrotising enterocolitis,
12.1 Gestation ≤ 28 weeks,7,483,"Risk Ratio (M‐H, Fixed, 95% CI)","1.79 [0.80, 4.01]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.79,0.8,4.01,12,1,Necrotising enterocolitis,Gestation ≤ 28 weeks
12.2 Gestation > 28 to 32 weeks,3,248,"Risk Ratio (M‐H, Fixed, 95% CI)","1.02 [0.23, 4.47]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.02,0.23,4.47,12,2,Necrotising enterocolitis,Gestation > 28 to 32 weeks
13 Chronic lung disease (28 days age) Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","1.27 [0.53, 3.05]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.27,0.53,3.05,13,,Chronic lung disease (28 days age),
13.1 Gestation ≤ 28 weeks,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","1.27 [0.53, 3.05]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.27,0.53,3.05,13,1,Chronic lung disease (28 days age),Gestation ≤ 28 weeks
14 Chronic lung disease (36 weeks' corrected age) Show forest plot,8,694,"Risk Ratio (M‐H, Fixed, 95% CI)","0.90 [0.72, 1.13]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.9,0.72,1.13,14,,Chronic lung disease (36 weeks' corrected age),
14.1 Gestation ≤ 28 weeks,8,411,"Risk Ratio (M‐H, Fixed, 95% CI)","0.90 [0.72, 1.13]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.9,0.72,1.13,14,1,Chronic lung disease (36 weeks' corrected age),Gestation ≤ 28 weeks
14.2 Gestation > 28 to 32 weeks,3,283,"Risk Ratio (M‐H, Fixed, 95% CI)","0.92 [0.36, 2.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.92,0.36,2.33,14,2,Chronic lung disease (36 weeks' corrected age),Gestation > 28 to 32 weeks
15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) Show forest plot,1,60,"Mean Difference (IV, Fixed, 95% CI)","1.06 [‐2.63, 4.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.06,-2.63,4.75,15,,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),
15.1 Gestation ≤ 28 weeks,1,60,"Mean Difference (IV, Fixed, 95% CI)","1.06 [‐2.63, 4.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.06,-2.63,4.75,15,1,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),Gestation ≤ 28 weeks
16 Duration of respiratory support (mechanical ventilation) (days from birth) Show forest plot,2,120,"Mean Difference (IV, Fixed, 95% CI)","‐13.64 [‐32.62, 5.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,-13.64,-32.62,5.33,16,,Duration of respiratory support (mechanical ventilation) (days from birth),
16.1 Gestation ≤ 28 weeks,2,120,"Mean Difference (IV, Fixed, 95% CI)","‐13.64 [‐32.62, 5.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,-13.64,-32.62,5.33,16,1,Duration of respiratory support (mechanical ventilation) (days from birth),Gestation ≤ 28 weeks
17 Duration of respiratory support (CPAP) (days from birth) Show forest plot,2,120,"Mean Difference (IV, Fixed, 95% CI)","‐2.09 [‐12.85, 8.67]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,-2.09,-12.85,8.67,17,,Duration of respiratory support (CPAP) (days from birth),
17.1 Gestation ≤ 28 weeks,2,120,"Mean Difference (IV, Fixed, 95% CI)","‐2.09 [‐12.85, 8.67]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,-2.09,-12.85,8.67,17,1,Duration of respiratory support (CPAP) (days from birth),Gestation ≤ 28 weeks
18 Duration of supplemental oxygen administration Show forest plot,3,180,"Mean Difference (IV, Fixed, 95% CI)","‐0.50 [‐16.90, 15.91]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,-0.5,-16.9,15.91,18,,Duration of supplemental oxygen administration,
18.1 Gestation ≤ 28 weeks,3,180,"Mean Difference (IV, Fixed, 95% CI)","‐0.50 [‐16.90, 15.91]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,-0.5,-16.9,15.91,18,1,Duration of supplemental oxygen administration,Gestation ≤ 28 weeks
19 Mortality to follow up (> 18 months) Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.55 [0.20, 1.53]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.55,0.2,1.53,19,,Mortality to follow up (> 18 months),
19.1 Gestation ≤ 28 weeks,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.55 [0.20, 1.53]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.55,0.2,1.53,19,1,Mortality to follow up (> 18 months),Gestation ≤ 28 weeks
20 Postnatal growth failure (weight < 10th percentile at discharge) Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.86 [0.55, 1.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.86,0.55,1.33,20,,Postnatal growth failure (weight < 10th percentile at discharge),
20.1 Gestation ≤ 28 weeks,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.86 [0.55, 1.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.86,0.55,1.33,20,1,Postnatal growth failure (weight < 10th percentile at discharge),Gestation ≤ 28 weeks
21 Duration of hospitalisation (days) Show forest plot,1,60,"Mean Difference (IV, Fixed, 95% CI)","28.0 [‐8.96, 64.96]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,28.0,-8.96,64.96,21,,Duration of hospitalisation (days),
21.1 Gestation ≤ 28 weeks,1,60,"Mean Difference (IV, Fixed, 95% CI)","28.0 [‐8.96, 64.96]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,28.0,-8.96,64.96,21,1,Duration of hospitalisation (days),Gestation ≤ 28 weeks
22 Patent ductus arteriosus (not prespecified) Show forest plot,7,710,"Risk Ratio (M‐H, Fixed, 95% CI)","0.96 [0.81, 1.14]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.96,0.81,1.14,22,,Patent ductus arteriosus (not prespecified),
22.1 Gestation ≤ 28 weeks,7,483,"Risk Ratio (M‐H, Fixed, 95% CI)","0.95 [0.80, 1.14]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,0.95,0.8,1.14,22,1,Patent ductus arteriosus (not prespecified),Gestation ≤ 28 weeks
22.2 Gestation > 28 to 32 weeks,2,227,"Risk Ratio (M‐H, Fixed, 95% CI)","1.05 [0.54, 2.05]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age,5,1.05,0.54,2.05,22,2,Patent ductus arteriosus (not prespecified),Gestation > 28 to 32 weeks
1 Mortality near term corrected age or discharge (latest reported) Show forest plot,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","0.51 [0.25, 1.07]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,0.51,0.25,1.07,1,,Mortality near term corrected age or discharge (latest reported),
2 Neurodevelopmental disability Show forest plot,2,208,"Risk Ratio (M‐H, Fixed, 95% CI)","0.82 [0.49, 1.35]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,0.82,0.49,1.35,2,,Neurodevelopmental disability,
3 IPPV in the delivery room Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","1.0 [0.94, 1.07]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,1.0,0.94,1.07,3,,IPPV in the delivery room,
4 Intubation in the delivery room Show forest plot,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","1.16 [0.79, 1.70]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,1.16,0.79,1.7,4,,Intubation in the delivery room,
5 Time to reach desired oxygen saturation target Show forest plot,1,60,"Mean Difference (IV, Fixed, 95% CI)","2.09 [‐0.26, 4.44]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,2.09,-0.26,4.44,5,,Time to reach desired oxygen saturation target,
6 Time to reach heart rate > 100 bpm (not prespecified) Show forest plot,1,60,"Mean Difference (IV, Fixed, 95% CI)","0.27 [‐1.21, 1.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,0.27,-1.21,1.75,6,,Time to reach heart rate > 100 bpm (not prespecified),
7 Retinopathy of prematurity Show forest plot,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","0.85 [0.39, 1.86]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,0.85,0.39,1.86,7,,Retinopathy of prematurity,
8 Severe retinopathy of prematurity (≥ stage 3) Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","3.86 [0.19, 77.05]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,3.86,0.19,77.05,8,,Severe retinopathy of prematurity (≥ stage 3),
9 Intraventricular haemorrhage Show forest plot,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","0.85 [0.47, 1.53]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,0.85,0.47,1.53,9,,Intraventricular haemorrhage,
10 Severe intraventricular haemorrhage (grade 3 or 4) Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.76 [0.17, 3.48]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,0.76,0.17,3.48,10,,Severe intraventricular haemorrhage (grade 3 or 4),
11 Necrotising enterocolitis Show forest plot,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","1.54 [0.46, 5.19]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,1.54,0.46,5.19,11,,Necrotising enterocolitis,
12 Chronic lung disease (28 days age) Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","1.27 [0.53, 3.05]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,1.27,0.53,3.05,12,,Chronic lung disease (28 days age),
13 Chronic lung disease (36 weeks' corrected age) Show forest plot,2,243,"Risk Ratio (M‐H, Fixed, 95% CI)","1.49 [0.90, 2.47]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,1.49,0.9,2.47,13,,Chronic lung disease (36 weeks' corrected age),
14 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) Show forest plot,1,60,"Mean Difference (IV, Fixed, 95% CI)","1.06 [‐2.63, 4.75]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,1.06,-2.63,4.75,14,,Duration of respiratory support (mechanical ventilation or CPAP) (days from birth),
15 Duration of respiratory support (mechanical ventilation) (days from birth) Show forest plot,1,193,"Mean Difference (IV, Fixed, 95% CI)","1.25 [‐0.97, 3.47]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,1.25,-0.97,3.47,15,,Duration of respiratory support (mechanical ventilation) (days from birth),
16 Duration of supplemental oxygen administration Show forest plot,2,253,"Mean Difference (IV, Fixed, 95% CI)","2.72 [‐2.78, 8.22]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,2.72,-2.78,8.22,16,,Duration of supplemental oxygen administration,
17 Mortality to follow up (> 18 months) Show forest plot,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","0.56 [0.28, 1.14]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,0.56,0.28,1.14,17,,Mortality to follow up (> 18 months),
18 Postnatal growth failure (weight < 10th percentile at discharge) Show forest plot,1,60,"Risk Ratio (M‐H, Fixed, 95% CI)","0.86 [0.55, 1.33]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,0.86,0.55,1.33,18,,Postnatal growth failure (weight < 10th percentile at discharge),
19 Duration of hospitalisation (days) Show forest plot,1,60,"Mean Difference (IV, Fixed, 95% CI)","28.0 [‐8.96, 64.96]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,28.0,-8.96,64.96,19,,Duration of hospitalisation (days),
20 Patent ductus arteriosus (not prespecified) Show forest plot,2,253,"Risk Ratio (M‐H, Fixed, 95% CI)","1.18 [0.88, 1.59]",Lower (FiO2 < 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis,6,1.18,0.88,1.59,20,,Patent ductus arteriosus (not prespecified),
